---
title: Why Silicon Valley Stopped Taking Nicotinamide (And Switched to This)
description: First direct human comparison reveals gut bacteria convert NAD+ precursors
  to boost longevity molecules
date: '2026-02-16'
category: Research
featured: false
author: Longevity Leak Research Team
studyUrl: https://www.nature.com/articles/s42255-025-01421-8
published: true
---
# Why Silicon Valley Stopped Taking Nicotinamide (And Switched to This)

## Key Findings

- NMN and NR increased NAD+ by 130-150% after 14 days
- Nicotinamide showed only transient 4-hour effects
- Gut bacteria convert precursors to nicotinic acid
- Both enhanced gut health markers


## Study Overview

Recent research from Nature Metabolism, Nestle Health Science has revealed important insights into longevity and healthy aging. This breakthrough represents a significant advance in our understanding of how to maintain health as we age.

## Clinical Significance

The findings from this study provide evidence-based approaches to age-related health optimization. Researchers measured specific biomarkers and physiological outcomes to validate the intervention's effectiveness.

## Methodology

The study employed rigorous scientific methods to ensure reliable, reproducible results. Researchers carefully controlled variables and used standardized measurement protocols throughout the investigation.

## Results Analysis

The data demonstrates measurable improvements in key health markers. Statistical analysis confirmed the significance of the observed changes, with effects sustained throughout the study period.

## Practical Implications

These findings suggest potential applications for healthy aging strategies. The research provides a foundation for understanding how specific interventions may support longevity pathways in the human body.

## Future Research Directions

Additional studies will help clarify optimal dosing, timing, and population-specific responses. Long-term follow-up trials are needed to assess sustained benefits and safety profiles.

## Source Documentation

Access the original full-text paper for deeper clinical validation.

[Read Full Study â†’](https://www.nature.com/articles/s42255-025-01421-8)



**[STRONG EVIDENCE]**

## How It Works: The Molecular Mechanism

NAD+ (nicotinamide adenine dinucleotide) is essential for cellular energy production via the electron transport chain and serves as a substrate for sirtuins, PARPs (DNA repair enzymes), and CD38 (immune regulator) [1]. NMN (nicotinamide mononucleotide) converts to NAD+ via NMNAT enzymes, while NR (nicotinamide riboside) converts via NRK1/2 kinases. Both bypass the rate-limiting NAMPT enzyme in the salvage pathway [2]. NAD+ levels decline 50% from age 40-60, impairing mitochondrial function and DNA repair capacity.

## What the Research Doesn't Tell Us

Despite strong evidence for NAD+ elevation:

- **Long-term outcomes**: No trials exceed 1 year - we lack data on sustained use benefits
- **Optimal precursor**: NMN vs NR debate continues - both work, but individual response varies [1]
- **Dosing precision**: Studies use 250-1000mg/day, but optimal dose by age/health status unknown
- **Tissue distribution**: Blood NAD+ rises, but brain and muscle NAD+ changes less clear [2]
- **CD38 expression**: High CD38 (inflammation marker) may blunt NAD+ increases - no personalized protocols yet

The evidence for NAD+ elevation is strong; evidence for downstream health outcomes (longevity, disease prevention) is still emerging.

## Maximizing Absorption

**NMN vs NR considerations**:
- **NMN**: Absorbed intact through gut transporter (Slc12a8), converts to NAD+ in cells
- **NR**: Absorbed as NR, phosphorylated by NRK enzymes to NMN, then to NAD+
- **Both work**: Choose based on tolerance and cost [1]

**Optimization strategies**:
- **Timing**: Morning on empty stomach (30 min before food) for peak absorption
- **Sublingual NMN**: May bypass gut metabolism (emerging research, not definitive)
- **Avoid heat**: NMN and NR are heat-sensitive - store in cool, dark place
- **Consistency**: Daily dosing maintains elevated NAD+ levels

**Dosing**: Studies show benefits at 250-1000mg/day. Start at 250mg, increase based on response [2].

## Safety Considerations

**Drug Interactions**:
- Minimal known interactions (NAD+ is endogenous molecule)
- Theoretical concern with medications affecting methylation pathways

**Contraindications**:
- Pregnancy/breastfeeding: No safety data - avoid
- Active cancer: NAD+ supports rapid cell division - discuss with oncologist before use

**Side Effects** (uncommon, usually mild):
- Flushing, mild nausea (especially at high doses)
- Insomnia if taken late in day (cellular energy activation)
- Rare: Skin rash, headache

**Long-term safety**: Human trials up to 1 year show excellent tolerability. NR has Generally Recognized as Safe (GRAS) status from FDA. NMN lacks formal approval but shows similar safety profile [3].

**Who should consider**: Individuals over 40 (when NAD+ decline accelerates), those with metabolic concerns, or high oxidative stress.

## Sources

[1] Christen S, et al. (2026). 'Differential impact of NAD+ boosters on circulatory NAD metabolism.' *Nat Metab*. DOI: 10.1038/s42255-025-01421-8

[2] Yoshino M, et al. (2021). 'Nicotinamide mononucleotide increases muscle insulin sensitivity in prediabetic women.' *Science*. PMID: 33888596

[3] Martens CR, et al. (2018). 'Chronic nicotinamide riboside supplementation elevates NAD+ in healthy middle-aged adults.' *Nat Commun*. PMID: 29725010